The program will focus on developing Proprio’s navigation platform which integrates robotics, computer vision and graphics processing technologies. The system is designed to reduce the complexity of surgical procedures and facilitate medical training.
Working with the Proprio development team, residents and fellows at the New York City-based medical school will have the opportunity to contribute to product requirements, test versions of the system, provide surgical guidance and conduct clinical trials.
After FDA clearance, the company plans to integrate units at the medical school for in situ studies.
“We believe leading programs like NYU Grossman School of Medicine can play a key role in the design of surgeon-centric products,” Gabriel Jones, Proprio’s co-founder and CEO said in a Jan. 21 news release. “Working with their department of neurosurgery will help us bring to market an imaging and navigation system that lets surgeons focus on the patient in an entirely new way.”
More articles on spine:
Outpatient migration will push more ASCs to invest in robotics, says Dr. Vladimir Sinkov
DOJ recovers $2.2B under False Claims Act — 2 orthopedic cases at center of FY 2020
Spine surgeon began using robot 1 year ago; now uses it in half of cases
